Owner Scorecard


← All companies ← MMS Manual MNKD → ← MMM Medical Devices & Equipment MSA →

MMSI, Merit Medical Systems

Medical Devices & Equipment capital-intensive Cyclical

Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy.

Our first product was a specialized control syringe used to inject contrast solution into a patient's arteries for a diagnostic cardiac procedure called an angiogram.

Since that time, our products and product lines have expanded substantially, both through internal research and development projects and through strategic acquisitions.

Latest annual: FY2025 10-K
MMSI · Merit Medical Systems
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$1.5B
+11.8% YoY · 9% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $1.6B 5-yr avg $1.3B
Gross margin 50% 5-yr avg 47%
Operating margin 12.8% 5-yr avg 9.4%
ROIC 8% 5-yr avg 7%
Owner-earnings margin 13% 5-yr avg 11%
Free cash flow margin 13% 5-yr avg 11%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What it is
Revenue is Cardiovascular (95%) and Endoscopy (5%).
Situation
Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power.
What moves the needle
Gross margin has run about 45% and operating margin about 6.2% through the cycle, a spread the cycle sets more than the company does. The margin is cyclical, swinging between −0.2% and 12% over the years, so the through-cycle figure carries more than any single year — and the balance sheet at the trough more than the peak. Inventory runs near 22% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median 4%, above 15% in 0 of 10 years). By owner earnings: roughly 7% of revenue reaches owners as cash, consistently. The cycle and the balance sheet decide this one; the worst year tells more than the median, and the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

The biggest segment, Cardiovascular, is also where the profit is made: 95% of revenue and 90% of segment operating profit.

Revenue by reportable segment, FY2025
Operating profit same segments
  • Cardiovascular95%$1.4B90% of profit
  • Endoscopy5%$73M10% of profit
By geographyUnited States60%International40%

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

Most recent quarterly filing 10-Q filed Jul 30, 2026 Source at SEC EDGAR →

Revenue up 9.5% year over year; operating income up 28.8%

“Sales for the six-month period ended June 30, 2026 were favorably affected by increased sales within the following platforms: (a) Access, which increased by $26.4 million, or 9.2%, from the corresponding period of 2025. This increase was driven primarily by increased sales of our sensors, fluid management and access products, partially offset by decreased sales in our kits, intervention and CRM/EP products.”

figures computed from the filing's XBRL; the words are the company's

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMJun 2026
Income statement
$604M$728M$883M$995M$964M$1.1B$1.2B$1.3B$1.4B$1.5B$1.6BRevenueRevenue
$265M$326M$395M$432M$401M$485M$519M$584M$643M$738M$782MGross profitGross prof.
44%45%45%43%42%45%45%46%47%49%50%Gross marginGross mgn
31%31%31%33%31%31%30%30%29%30%31%SG&A / revenueSG&A/rev
7%7%7%7%6%7%7%7%6%6%6%R&D / revenueR&D/rev
$35M$33M$59M$15M($2M)$61M$88M$124M$156M$185M$201MOperating incomeOp. inc.
5.8%4.5%6.6%1.6%−0.2%5.7%7.6%9.9%11.5%12.2%12.8%Operating marginOp. mgn
$25M$36M$50M$2M($13M)$54M$83M$112M$150M$171MPretax incomePretax
$20M$28M$42M$5M($10M)$48M$75M$94M$120M$128M$146MNet incomeNet inc.
21%23%15%10%10%16%20%25%25%Effective tax rateTax rate
Cash flow & returns
$54M$63M$87M$78M$165M$147M$114M$145M$221M$297M$283MOperating cash flowOp. cash
$44M$54M$70M$92M$94M$84M$82M$90M$103M$123M$124MDepreciationDeprec.
($13M)($22M)($31M)($29M)$67M($1M)($60M)($61M)($31M)$2M($32M)Working capital & otherWC & other
$33M$39M$63M$78M$46M$28M$45M$34M$35M$82M$80MCapexCapex
5.4%5.3%7.2%7.9%4.8%2.6%3.9%2.7%2.6%5.4%5.1%Capex / revenueCapex/rev
$21M$24M$23M($360K)$119M$119M$69M$111M$186M$216M$203MOwner earningsOwner earn.
3.4%3.3%2.6%−0.0%12.4%11.1%6.0%8.8%13.7%14.2%12.9%Owner earnings marginOE mgn
$21M$24M$23M($360K)$119M$119M$69M$111M$186M$216M$203MFree cash flowFCF
3.4%3.3%2.6%−0.0%12.4%11.1%6.0%8.8%13.7%14.2%12.9%Free cash flow marginFCF mgn
$125M$106M$302M$54M$11M$7M$7M$135M$320M$145M$115MAcquisitionsAcquis.
($159M)($147M)($379M)($134M)($59M)($37M)($57M)($175M)($369M)($247M)Investing cash flowInv. cash
$121M$97M$328M$34M($96M)($98M)($60M)$559M($60M)$16MFinancing cash flowFin. cash
($593K)$682K($970K)$96K$2M($801K)($4M)($484K)($3M)$4MExchange-rate effectFX
$15M$13M$35M($23M)$13M$11M($7M)$529M($210M)$70MChange in cashΔ cash
3%3%4%1%-0%5%6%7%7%7%8%ROICROIC
4%4%5%1%-1%5%7%8%9%8%9%Return on equityROE
4%4%5%1%−1%5%7%8%9%8%9%Retained to equityRetained/eq
Balance sheet
$19M$32M$67M$44M$57M$68M$58M$587M$377M$446M$449MCash & investmentsCash+inv
$81M$106M$137M$155M$147M$152M$165M$178M$190M$204M$224MReceivablesReceiv.
$121M$155M$198M$226M$198M$222M$266M$304M$306M$334M$374MInventoryInvent.
$31M$35M$54M$55M$50M$56M$69M$66M$69M$61M$71MAccounts payablePayables
$171M$226M$281M$326M$295M$319M$362M$416M$428M$477M$528MOperating working capitalOper. WC
$243M$316M$430M$455M$430M$482M$529M$1.1B$924M$1.0B$1.1BCurrent assetsCur. assets
$88M$116M$175M$182M$185M$236M$221M$204M$216M$240M$265MCurrent liabilitiesCur. liab.
2.8×2.7×2.5×2.5×2.3×2.0×2.4×5.4×4.3×4.3×4.2×Current ratioCurr. ratio
$277M$293M$331M$379M$383M$372M$383M$384M$386M$428MNet PP&ENet PP&E
$212M$238M$335M$353M$364M$362M$360M$382M$464M$507M$540MGoodwillGoodwill
$943M$1.1B$1.6B$1.8B$1.7B$1.6B$1.7B$2.3B$2.4B$2.7B$2.9BTotal assetsAssets
$324M$278M$395M$439M$351M$243M$198M$823M$730M$734M$740MTotal debtDebt
$305M$246M$328M$395M$294M$175M$140M$236M$353M$288M$291MNet debt / (cash)Net debt
4.0×4.3×5.7×1.2×-0.2×11.6×13.8×8.0×5.0×7.0×6.3×Interest coverageInt. cov.
$445M$435M$687M$807M$706M$608M$520M$1.1B$1.0B$1.1BTotal liabilitiesTotal liab.
$498M$676M$933M$950M$959M$1.0B$1.1B$1.2B$1.4B$1.6B$1.7BShareholders’ equityEquity
0.4%0.6%0.7%0.9%1.5%1.5%1.6%1.7%2.1%2.9%2.9%Stock comp / revenueSBC/rev
$988K$313K$497KGoodwill written downGW imp.
Per share
44.9M50.1M53.9M56.2M55.4M57.4M57.7M58.4M59.4M60.5M60.0MShares out (diluted)Shares
$13.46$14.53$16.37$17.69$17.39$18.74$19.96$21.55$22.85$25.07$26.31Revenue / shareRev/sh
$0.45$0.55$0.78$0.10$-0.18$0.84$1.29$1.62$2.03$2.13$2.43EPS (diluted)EPS
$0.46$0.48$0.43$-0.01$2.15$2.08$1.20$1.90$3.13$3.57$3.39Owner earnings / shareOE/sh
$0.46$0.48$0.43$-0.01$2.15$2.08$1.20$1.90$3.13$3.57$3.39Free cash flow / shareFCF/sh
$0.73$0.77$1.17$1.39$0.83$0.49$0.78$0.59$0.59$1.35$1.34Cap. spending / shareCapex/sh
$11.10$13.50$17.30$16.89$17.29$18.13$19.84$20.60$23.24$26.20$27.99Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+7.2%/yr+7.6%/yr
Owner earnings / share+25.5%/yr+10.6%/yr
EPS+18.9%/yr
Capital spending / share+7.1%/yr+10.3%/yr
Book value / share+10.0%/yr+8.7%/yr

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $128M of profit into $216M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$128M
Owner earnings$216M · 14% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$128M$120M$94M$75M$48M
Depreciation & amortizationnon-cash charge added back+$123M+$103M+$90M+$82M+$84M
Stock-based compensationreal costnon-cash, but a real cost+$43M+$28M+$21M+$18M+$16M
Working capital & othertiming of cash in and out, other non-cash items+$2M−$31M−$61M−$60M−$1M
Cash from operations$297M$221M$145M$114M$147M
Capital expenditurecash put back in to keep running and to grow−$82M−$35M−$34M−$45M−$28M
Owner earnings$216M$186M$111M$69M$119M
Owner-earnings marginowner earnings ÷ revenue14%14%9%6%11%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $43M), owner earnings is nearer $172M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $185M ÷ interest expense $26M
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • How heavy is the debt, net of cash? $299M · 1.6× operating profit
    Modest net debt
    Cash $446M − debt $745M
    What this means

    Netting $446M of cash and short-term investments against $745M of debt leaves $299M owed, about 1.6× a year's operating profit (4.0× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 49 + DIO 157 − DPO 28 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Below average through the cycle
    10-yr median, range -0%–7%; 7% latest = NOPAT $139M ÷ invested capital $1.9B
    Industry peers: median 4%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 7% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Solid through the cycle
    10-yr median margin, range -0%–14%; latest $216M = operating cash $297M − maintenance capex $82M
    Industry peers: median 5%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 14% of revenue this year, a 7% median across 10 years. Treating stock comp as the real expense it is (less $43M of SBC) leaves $172M.

  • Cash-backed
    Cash from ops $297M ÷ net income $128M
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 0.66×
    Harvesting
    Capex $82M ÷ depreciation $123M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Is the buyback buying ownership, or mopping up? 2.9%
    The count is rising
    Stock compensation $43M (fiscal 2025), 2.9% of revenue · no repurchases · diluted shares +4.8% since 2022
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 3 of 5 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Near
    Revenue ≥ $2B · $1.5B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 4.34×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $745M vs $800M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Near
    A profit every year (10-yr record) · 1 loss year
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record
    Uninterrupted dividends · no dividend line tagged in the data
    What this means

    An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.

  • Earnings growth Pass
    Earnings +33% over the record · +283%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $1.92/share (latest year $2.15), the averaged base the calculator's gate runs on, and book value is $26.53/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 9 of 10
    What this means

    Lost money in 1 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 0 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 6% → 11% (3-yr avg ends)
    What this means

    Through the cycle the operating margin widened — about 6% early to 11% lately, median 6% — pricing power intact or improving.

  • Reinvestment, incremental ROIC 13%
    What this means

    Reinvested capital came back at only a modest incremental return — near the cost of capital, where extra growth adds little per dollar. The record shows whether it is a soft stretch or a thinning moat.

  • Owner earnings growth +28%/yr
    What this means

    Owner earnings grew about 28% a year over the record.

  • Worst year 2020 · −0.2% op. margin
    What this means

    Operations went underwater in 2020, understand why before trusting the good years.

  • Share count +3.4%/yr
    What this means

    The share count is rising, dilution works against you on a per-share basis.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$1.1B
  • Cash & short-term investments$449M
  • Receivables$224M
  • Inventory$374M
  • Other current assets$65M
Current liabilities$265M
  • Debt due within a year$4M
  • Accounts payable$71M
  • Other current liabilities$190M
Current ratio4.20×all current assets ÷ what's due · Graham looked for 2×
Quick ratio2.79×stricter: inventory excluded
Cash ratio1.69×strictest: cash alone against what's due
Working capital$847Mthe cushion left after near-term bills
Debt due this year vs. cash$4M due · $449M cash covered by cash on hand, no refinancing forced · both figures from the Jun 30, 2026 balance sheet
Revenue, latest quarter vs. a year ago+9.5%the freshest read on whether the business is still growing
Current ratio, recent quarters5.4× → 4.2×
Deeper floors
Tangible book value$1.1Bequity stripped of goodwill & intangibles
Net current asset value($72M)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$824M$84M of it operating leases
Deferred revenue$1Mcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $1.4B of operating cash; how management split it reads as a cash builder, a large share of cash simply built up on the balance sheet.

  • Reinvested$483M · 35%
  • Retained (debt / cash)$888M · 65%
  • Source of fundingOperating cash

    Operating cash covered reinvestment and returns; over the span debt rose $416M and cash and short-term investments rose $430M.

  • Net change in share count33.8%

    The diluted count rose from 45M to 60M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.

  • Dividend record

    No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

  • Return on what it retained27%

    Of the earnings it kept rather than paid out ($551M over the span), annual owner earnings (first three years vs last three) grew $148M, so each retained $1 added about 0.27 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill$507M19% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity32%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$1.2Bover 10 years buying other businesses, against $483M of capital spent building

$1M written down across 2 years (2017, 2025): goodwill the company has already conceded it overpaid for, charged against earnings. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearPay, as filed“Actually paid”Owner earnings
2021$7.5M$10.7M$119M
2022$8.1M$12.1M$69M
2023$10.1M$9.8M$111M
2024$10.4M$16.4M$186M
2025$6.7M$7.1M$216M
2025$13.8M$9.9M$216M

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • CEO pay ratio184:1

    What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.

  • Stock-based compensation$43M

    The slice of the business handed to employees in shares in fiscal 2025, 2.9% of revenue, equal to 23.5% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Inventory, Acquisitions as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each column names the period it is read over; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
ICUIICU Medical$2.2B37%2.0%5%5%
TFXTeleflex$2.0B55%16.6%7%13%
IARTIntegra Lifesciences Holdings Corp$1.6B62%7.4%4%8%
MMSIMerit Medical Systems$1.5B45%6.2%4%7%
PENPenumbra$1.4B65%0.5%0%3%
HAEHaemonetics$1.3B50%10.4%7%11%
TNDMTandem Diabetes Care$1.0B52%-15.0%-24%-1%
INSPInspire Medical Systems$912M84%-28.7%-19%-23%
Group median53%4.1%4%6%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Merit Medical Systems has delivered.

Merit Medical Systems’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

$

Through the cycle, Merit Medical Systems earns about $112M on its 7.4% median owner-earnings margin. This year’s 14.2% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base

The assumptions

9.0% = the 4.68% 10-year Treasury (Jul 30, 2026) + 4.32 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25+21%/yr
Owner-earnings growth · ’16→’25+28%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.68%, as of Jul 30, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $203M on 60M shares outstanding, per the 10-Q cover, as of 2026-07-28; net debt $291M. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Merit Medical Systems (MMSI), the owner's record," https://ownerscorecard.com/c/MMSI, data as of 2026-07-18.

Manual order: ← MMS its page in the Manual MNKD →

Industry order: ← MMM the Medical Devices & Equipment chapter MSA →